Bloodwork Panels for Peptide Users

Running peptides without baseline bloodwork is like driving without a fuel gauge. You might be fine. You also might not notice when something quietly shifts until it's a problem.

Bloodwork isn't about being paranoid. It's about having numbers you can compare. If your fasting glucose was 92 before a GH peptide cycle and it's 112 two months in, that's information you can act on. Without the baseline, you just have a single data point and a shrug.

The core principle

Every peptide class nudges a specific physiological system — growth hormone axis, glucose handling, inflammation, appetite regulation. The labs you want are the ones that reflect that system. Running unnecessary panels wastes money. Running too few leaves you guessing.

Three timing windows matter:

• Baseline — 1–2 weeks before starting. Captures your normal.
• Mid-cycle — 4–8 weeks in, depending on protocol length. Catches drift early.
• Post-cycle — 2–4 weeks after stopping. Shows whether markers normalized.

The recommended panel

Test	What it measures	Why it matters	Relevant peptide classes
CBC (complete blood count)	Red/white cells, platelets, hematocrit	Baseline health, detects infection or marrow suppression	All
CMP (comprehensive metabolic panel)	Kidneys, liver, electrolytes, glucose	Organ function — peptides are cleared by liver/kidney	All
Fasting glucose	Blood sugar at rest	GH peptides can push it up; GLP-1s pull it down	GH axis, GLP-1
HbA1c	3-month glucose average	Catches gradual insulin resistance	GH axis, GLP-1
Fasting insulin	Pancreatic output at rest	Paired with glucose = HOMA-IR (insulin sensitivity)	GH axis, GLP-1
Lipid panel	LDL, HDL, triglycerides	Shifts with body composition changes and GH signaling	GH axis, fat-loss stacks
IGF-1	Growth hormone downstream marker	The only practical GH-axis readout	Sermorelin, Ipamorelin, CJC-1295, Tesamorelin
TSH + free T3/T4	Thyroid function	GH peptides can blunt thyroid; weight loss shifts it	GH axis, GLP-1
hs-CRP	Systemic inflammation	Healing peptides should lower it; infection raises it	BPC-157, TB-500, thymic peptides
ALT / AST	Liver enzymes (part of CMP)	Flagging hepatic stress early	All, especially long-duration users
eGFR / creatinine	Kidney filtration (part of CMP)	Peptide clearance and dehydration signal	All
Testosterone (total + free)	HPTA status	GH and GLP-1 changes can shift sex hormones via body comp	Long cycles, GH stacks
Estradiol	Aromatization and metabolic health	Shifts with fat loss / gain	GLP-1, long GH cycles
Vitamin D, B12, ferritin	Nutrient status	GLP-1 users often under-eat; affects recovery	GLP-1, calorie-restriction stacks

If budget is tight, the minimum viable panel is: CBC, CMP, HbA1c, fasting insulin, lipid panel, IGF-1, hs-CRP. That covers most of what you need to know for most peptides.

When to run what

Before any GH-axis peptide (sermorelin, ipamorelin, CJC-1295, tesamorelin): baseline IGF-1, fasting glucose, HbA1c, fasting insulin, lipid panel. You want to know where the GH axis sits and whether your glucose handling has headroom.

Before a GLP-1 protocol (semaglutide, tirzepatide): CMP, HbA1c, fasting insulin, lipid panel, thyroid, vitamin D / B12. If you're not diabetic, you're specifically watching for pancreas and gallbladder signals.

Before healing peptides (BPC-157, TB-500, thymic peptides): CBC, CMP, hs-CRP. These are generally lower-risk, but CRP gives you a healing-response baseline.

Mid-cycle (4–8 weeks in): repeat the markers most likely to drift. For GH peptides that's IGF-1, glucose, HbA1c. For GLP-1s it's CMP, HbA1c, lipids. For healing it's CRP.

Post-cycle (2–4 weeks after stopping): the same markers you tracked mid-cycle. The question you're answering is did my body return to baseline or did something shift?

Reading the numbers

Reference ranges on lab reports are wide on purpose — they cover most of the population. "Normal" isn't the same as "optimal for you." What matters more than any single number is the trend line compared to your baseline.

A lab that drifts steadily in one direction across three draws is a signal. A single out-of-range value on one draw is often noise — repeat it before you panic.

When to stop and see a doctor

Stop the protocol and get clinical eyes on any of the following: fasting glucose crossing into diabetic range (≥126 mg/dL), HbA1c above 6.4%, ALT or AST more than 2× the upper limit of normal, eGFR dropping more than 15 points, hs-CRP above 10 mg/L without obvious illness, IGF-1 above the upper reference range for your age, or any new abnormality you can't explain. Lab shifts are data, not emergencies — but "I'll check it next time" is how people miss real problems.

Where to get them

Direct-to-consumer labs (Quest/Labcorp via aggregators) run most of this panel for $100–$250 out of pocket, no prescription needed in most US states. A primary care provider will often order the same work if you ask — and having a clinician who knows what you're doing is worth more than the cost difference.

Where to go next

• Red flags: when to stop a protocol immediately covers the symptoms and values that warrant immediate discontinuation.
• Long-term monitoring: the yearly workup is the annual check for chronic users.
• Discuss specific lab results with the community in the Bloodwork & Metrics forum.

---

This is educational content, not medical advice. Abnormal labs or symptoms warrant consultation with a qualified healthcare provider.